Skip to main content
Top

Endocrine

Issue 2/2005

Content (13 Articles)

Introduction

Russel J. Reiter

The rhythm and blues of gene expression in the rodent pineal gland

Magdalena Karolczak, Horst-Werner Korf, Jörg H. Stehle

Functional MT1 and MT2 melatonin receptors in mammals

Margarita L. Dubocovich, Magdalena Markowska

Measurement of melatonin and its metabolites

Glaucia R. Martinez, Eduardo A. Almeida, Clécio F. Klitzke, Janice Onuki, Fernanda M. Prado, Marisa H. G. Medeiros, Paolo D. Mascio

On the role of melatonin in skin physiology and pathology

Andrzej Slominski, Tobias W. Fischer, Michal A. Zmijewski, Jacobo Wortsman, Igor Semak, Blazaj Zbytek, Radomir M. Slominski, Desmond J. Tobin

Physiological ischemia/reperfusion phenomena and their relation to endogenous melatonin production

Dun-Xian Tan, Lucien C. Manchester, Rosa M. Sainz, Juan C. Mayo, Josefa León, Russel J. Reiter

Melatonin and nitric oxide

Darío Acuña-Castroviejo, Germaine Escames, Luis C. López, Ana B. Hitos, Josefa León

Melatonin and parkinson’s disease

Juan C. Mayo, Rosa M. Sainz, Dun-Xian Tan, Isaac Antolín, Carmen Rodríguez, Russel J. Reiter

Putting cancer to sleep at night

David E. Blask, Robert T. Dauchy, Leonard A. Sauer

A review of the multiple actions of melatonin on the immune system

Antonio Carrillo-Vico, Juan M. Guerrero, Patricia J. Lardone, Russel J. Reiter

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.